N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide
C17H18N4O5S — CID 166214660
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide
N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide (PubChem CID 166214660) has the molecular formula C17H18N4O5S and a molecular weight of 390.42 g/mol. Its IUPAC name is N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide |
|---|---|
| PubChem CID | 166214660 |
| Molecular Formula | C17H18N4O5S |
| Molecular Weight | 390.42 g/mol |
| Exact Mass | 390.10 |
| IUPAC Name | N-[2-[5-[3-(2,3-dihydro-1-benzofuran-5-yl)-1,2-oxazol-5-yl]-1,2,4-oxadiazol-3-yl]propan-2-yl]methanesulfonamide |
| SMILES | CC(C)(NS(C)(=O)=O)c1noc(-c2cc(-c3ccc4c(c3)CCO4)no2)n1 |
| InChI | InChI=1S/C17H18N4O5S/c1-17(2,21-27(3,22)23)16-18-15(26-20-16)14-9-12(19-25-14)10-4-5-13-11(8-10)6-7-24-13/h4-5,8-9,21H,6-7H2,1-3H3 |
| InChIKey | ISANUKQIPMBPHW-UHFFFAOYSA-N |
| XLogP | 2.11 |
| TPSA | 120.35 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.42 |
| LogP ≤ 5 | 2.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166214660 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.